Our Applications
Instead of focusing on one target in artificial systems, we identify and validate pathologic signaling networks in models directly derived from patients. With this novel approach, targets and drug candidates discovered from our platform address novel disease mechanisms and display a markedly increased likelihood of being highly effective.
Single-Cell Transcriptomics
Dissect the complexity of heterogenous tissues at unparalleled resolution
We solve the key challenges in drug discovery with our technologies:
- Patient-derived human disease models minimize drug attrition compared to animal models
- Pathway-based drug discovery enables optimized target selection even in complex diseases
- Deeply stratified patient cohorts improve clinical trial design
In addition, Systasy offers viral tropism profiling for gene therapy development & single-cell/nucleous RNA Sequencing.
Collaboration is part of our DNA!
Ready to take your research to the next level? Contact us today to learn more about our services, pricing, and how we can help you achieve your scientific goals.
Ready to take your research to the next level? Contact us today to learn more about our services, pricing, and how we can help you achieve your scientific goals.